These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31344067)

  • 1. Recombinant proteins of Plasmodium malariae merozoite surface protein 1 (PmMSP1): Testing immunogenicity in the BALB/c model and potential use as diagnostic tool.
    Elizardez YB; Fotoran WL; Junior AJG; Curado I; Junior NK; Monteiro EF; Romero Neto I; Wunderlich G; Kirchgatter K
    PLoS One; 2019; 14(7):e0219629. PubMed ID: 31344067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural infections with different Plasmodium species induce antibodies reactive to a chimeric Plasmodium vivax recombinant protein.
    McCaffery JN; Singh B; Nace D; Moreno A; Udhayakumar V; Rogier E
    Malar J; 2021 Feb; 20(1):86. PubMed ID: 33579292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.
    Muerhoff AS; Birkenmeyer LG; Coffey R; Dille BJ; Barnwell JW; Collins WE; Sullivan JS; Dawson GJ; Desai SM
    Clin Vaccine Immunol; 2010 Oct; 17(10):1631-8. PubMed ID: 20702658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1
    Priest JW; Plucinski MM; Huber CS; Rogier E; Mao B; Gregory CJ; Candrinho B; Colborn J; Barnwell JW
    Malar J; 2018 Nov; 17(1):417. PubMed ID: 30413163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
    Ahlborg N; Ling IT; Holder AA; Riley EM
    Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
    Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
    Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
    Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
    Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of Plasmodium species infections in Zimbabwean population.
    Amanfo SA; Mduluza T; Midzi N; Cavanagh DR; Mutapi F
    Malar J; 2016 May; 15(1):267. PubMed ID: 27165412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
    Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
    J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A panel of recombinant proteins from human-infective Plasmodium species for serological surveillance.
    Müller-Sienerth N; Shilts J; Kadir KA; Yman V; Homann MV; Asghar M; Ngasala B; Singh B; Färnert A; Wright GJ
    Malar J; 2020 Jan; 19(1):31. PubMed ID: 31952523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA; Zakeri S; Rafati S; Salmanian AH; Djadid ND
    Parasite Immunol; 2011 Nov; 33(11):594-608. PubMed ID: 21883290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity and immunogenicity of the merozoite surface protein 1 C-terminal 19-kDa fragment of Plasmodium ovale imported from Africa into China.
    Xu Q; Liu S; Kassegne K; Yang B; Lu J; Sun Y; Zhong W; Zhang M; Liu Y; Zhu G; Cao J; Cheng Y
    Parasit Vectors; 2021 Nov; 14(1):583. PubMed ID: 34819151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
    Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].
    Cao Y; Zhang DM; Pan WQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.